L-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin.
about
Aging and the control of human skin blood flowHeat waves, aging, and human cardiovascular health.Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans.Rho kinase-mediated local cold-induced cutaneous vasoconstriction is augmented in aged human skin.Exercise prevents age-related decline in nitric-oxide-mediated vasodilator function in cutaneous microvessels.Nitrergic response to cyclophosphamide treatment in blood and bone marrowAscorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease.Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans.Piceatannol-3'-O-beta-D-glucopyranoside as an active component of rhubarb activates endothelial nitric oxide synthase through inhibition of arginase activity.Local tetrahydrobiopterin administration augments reflex cutaneous vasodilation through nitric oxide-dependent mechanisms in aged human skin.Nitric oxide and receptors for VIP and PACAP in cutaneous active vasodilation during heat stress in humans.Voluntary wheel running augments aortic l-arginine transport and endothelial function in rats with chronic kidney diseaseOxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.Oral sapropterin acutely augments reflex vasodilation in aged human skin through nitric oxide-dependent mechanisms.Nonuniform, age-related decrements in regional sweating and skin blood flow.Oral atorvastatin therapy increases nitric oxide-dependent cutaneous vasodilation in humans by decreasing ascorbate-sensitive oxidantsIs arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction?Mechanisms involved in the aging-induced vascular dysfunction.Blunted increases in skin sympathetic nerve activity are related to attenuated reflex vasodilation in aged human skin.L-arginine as dietary supplement for improving microvascular function.Impairments in central cardiovascular function contribute to attenuated reflex vasodilation in aged skin.iNOS-dependent sweating and eNOS-dependent cutaneous vasodilation are evident in younger adults, but are diminished in older adults exercising in the heatRole of arginase in vessel wall remodeling.Sustained cutaneous vasoconstriction during and following cyrotherapy treatment: Role of oxidative stress and Rho kinase.Endothelial aging associated with oxidative stress can be modulated by a healthy mediterranean dietArginase and vascular aging.Cutaneous blood flow during intradermal NO administration in young and older adults: roles for calcium-activated potassium channels and cyclooxygenase?Peripheral mechanisms of thermoregulatory control of skin blood flow in aged humansCurrent concepts of active vasodilation in human skin.Redox balance in the aging microcirculation: new friends, new foes, and new clinical directions.Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?Retrodialysis: a review of experimental and clinical applications of reverse microdialysis in the skin.Cutaneous vasodilator and vasoconstrictor mechanisms in temperature regulation.Arterial structure and function in vascular ageing: are you as old as your arteries?Pronounced and sustained cutaneous vasoconstriction during and following cyrotherapy treatment: Role of neurotransmitters released from sympathetic nerves.Local infusion of ascorbate augments NO-dependent cutaneous vasodilatation during intense exercise in the heat.Edward F. Adolph Distinguished Lecture: Skin-deep insights into vascular aging.Acute localized administration of tetrahydrobiopterin and chronic systemic atorvastatin treatment restore cutaneous microvascular function in hypercholesterolaemic humans.Oral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humans.Assessing N w-hydroxy-L-arginine applicability as a novel ethnic specific estrogen-negative breast cancer marker.
P2860
Q28394291-538644B9-2F78-41BC-9E6B-182768474156Q30771071-53CCE03D-D4D2-49D3-926E-8F922DD5F537Q33277505-15261A91-09DD-4AEC-84DC-C06702592436Q33281441-BB683EC5-E636-4986-8D11-F1F268056976Q33335053-0B602C06-74ED-4DE3-9A98-0CE2659FA2D7Q33381750-676DFCD2-CBE1-4AD1-A78A-9B446B0E78D6Q34008329-8693742B-BC04-4BEB-8FE6-1CFDD178A130Q34022778-E7D96B12-9727-44D4-92F0-66BAA449EA22Q34029838-B7A6ECC4-28BA-4379-A034-10238DBB9D4CQ34097506-0C0FCDD4-2771-4123-ADD6-901E2471FE1FQ34409375-DFD052B1-E565-4732-957D-0D8FC3F4AAD8Q34428925-D1BD2B04-DCF3-420F-BD9E-C5E8B0C8CC03Q34543359-71008B72-7495-48C8-965F-05821A952E64Q34762233-D7A9B9B2-C283-4AE5-9F37-4E06CE7BAC47Q34910013-4298B7BA-569B-4C33-BB24-BEC88012D4D2Q35217467-033E7F02-AE09-4613-B917-F42BD0696578Q35339312-1FAE3584-B601-4FFE-A142-1BCDB5AE9A71Q35990597-7BBD8B78-0CB3-411A-93E0-AD4B2721C270Q36176713-ED6B3BD8-0467-4E5C-9B4A-DFBCF130E330Q36182767-1CFFEE46-1F33-499B-829B-AD3A1177D678Q36382210-58731C10-C53A-4EB8-BAA9-FA543F532FB8Q36541465-C55EB53D-A245-4949-BF5E-7018E2761EA3Q36837617-EEF090B0-6A0A-420B-940C-D6922055013CQ36901981-646DB7D7-1677-404F-B4C7-91C1E548B5A2Q36913515-B09B9145-2311-47AA-A441-D91C307D6016Q36977086-8C0E3812-7FBB-4845-B9E3-EF37A432A43AQ37071835-6F5E695C-2A57-485F-862E-982FB85CF7CEQ37174305-E0C9DF69-F22D-470E-AE34-F765D33695B2Q37708221-73D6D6BC-16C3-4AC5-B3CD-4B51B6B7DEA2Q37939948-C2F948B7-C361-43F8-A8A2-47EE87E82911Q38082329-72FB3EAD-ECFD-4414-AE10-500BA70F4E5BQ38113357-6B99761F-D36B-44A7-8EF7-11BBBB30AF87Q38201379-8D4103DF-9696-4068-8D94-7183BAAA3B13Q38542436-818FEAC3-5D01-4F0D-A2EF-7B6A57B5553BQ38607850-ABD8C53E-7B14-4EA5-82F5-73B486B29C9FQ38991701-31435F63-6F46-45B1-8CC9-6B2C7633AAB2Q39448948-D0FF574B-0B54-4116-BBA2-3FEE8A106A07Q43525134-AAD908E4-E766-47EC-B1AD-3DA84883CF43Q44298564-B57BB422-ED8A-49E6-B84F-E38E93B3A2B4Q48089711-D9E0DAAB-2967-401B-9BB1-C755674CEF5B
P2860
L-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
L-Arginine supplementation or ...... dilatation in aged human skin.
@ast
L-Arginine supplementation or ...... dilatation in aged human skin.
@en
type
label
L-Arginine supplementation or ...... dilatation in aged human skin.
@ast
L-Arginine supplementation or ...... dilatation in aged human skin.
@en
prefLabel
L-Arginine supplementation or ...... dilatation in aged human skin.
@ast
L-Arginine supplementation or ...... dilatation in aged human skin.
@en
P2093
P2860
P1476
L-Arginine supplementation or ...... dilatation in aged human skin.
@en
P2093
Caitlin S Thompson
Lacy A Holowatz
W Larry Kenney
P2860
P304
P356
10.1113/JPHYSIOL.2006.108993
P407
P577
2006-05-04T00:00:00Z